Warsaw, Ind.-based Clinical Graphics produces 3D range-of-motion simulation technology designed to aid in making treatment decisions for hip conditions which require early interventions, including femoracetabular impingement and dysplasia.
“3D imaging represents the next generation of treating joint pain, and we’re excited to team up with Clinical Graphics and integrate our technologies to further enhance the clinical utility of our market leading hip portfolio,” Zimmer Biomet joint reconstruction president Dan Williamson said in prepared remarks.
Zimmer Biomet said it plans to integrate the newly acquired imaging platform into its hip preservation portfolio.
“Zimmer Biomet is a well-respected leader in musculoskeletal healthcare, and an ideal parent company to usher our breakthrough technologies into mainstream clinical practice as the standard of care for managing joint disease. We’re thrilled to join the Zimmer Biomet family and look forward to working together to improve the care of patients living with joint pain,” Clinical Graphics managing director Peter Krekel said in prepared remarks.
Last month, Zimmer Biomet said it paid an unspecified amount to acquire CD Diagnostics and its line of immunoassay and biomarker products.
Four years ago, the duo inked a pact that led to the development and marketing of the Synovasure periprosthetic joint infection test, Warsaw, Ind.-based Zimmer Biomet said.